Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics
<p>Includes the list of peptides derived from NSM identified at 0.02 FDR and ALC>=30</p>
שמור ב:
| מחבר ראשי: | |
|---|---|
| מחברים אחרים: | , , , , , , , , , , , , , , , , , , |
| יצא לאור: |
2025
|
| נושאים: | |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
| _version_ | 1849927632908451840 |
|---|---|
| author | Maria Lozano-Rabella (15056515) |
| author2 | Andrea Garcia-Garijo (15056518) Jara Palomero (15056521) Anna Yuste-Estevanez (15056524) Florian Erhard (15056527) Roc Farriol-Duran (15056530) Juan Martín-Liberal (15056533) Maria Ochoa-de-Olza (15056536) Ignacio Matos (15056539) Jared J. Gartner (15046103) Michael Ghosh (15056542) Francesc Canals (15056545) August Vidal (15056548) Josep Maria Piulats (15056551) Xavier Matías-Guiu (15056554) Irene Brana (15056557) Eva Muñoz-Couselo (14957498) Elena Garralda (15039090) Andreas Schlosser (15056560) Alena Gros (15056563) |
| author2_role | author author author author author author author author author author author author author author author author author author author |
| author_facet | Maria Lozano-Rabella (15056515) Andrea Garcia-Garijo (15056518) Jara Palomero (15056521) Anna Yuste-Estevanez (15056524) Florian Erhard (15056527) Roc Farriol-Duran (15056530) Juan Martín-Liberal (15056533) Maria Ochoa-de-Olza (15056536) Ignacio Matos (15056539) Jared J. Gartner (15046103) Michael Ghosh (15056542) Francesc Canals (15056545) August Vidal (15056548) Josep Maria Piulats (15056551) Xavier Matías-Guiu (15056554) Irene Brana (15056557) Eva Muñoz-Couselo (14957498) Elena Garralda (15039090) Andreas Schlosser (15056560) Alena Gros (15056563) |
| author_role | author |
| dc.creator.none.fl_str_mv | Maria Lozano-Rabella (15056515) Andrea Garcia-Garijo (15056518) Jara Palomero (15056521) Anna Yuste-Estevanez (15056524) Florian Erhard (15056527) Roc Farriol-Duran (15056530) Juan Martín-Liberal (15056533) Maria Ochoa-de-Olza (15056536) Ignacio Matos (15056539) Jared J. Gartner (15046103) Michael Ghosh (15056542) Francesc Canals (15056545) August Vidal (15056548) Josep Maria Piulats (15056551) Xavier Matías-Guiu (15056554) Irene Brana (15056557) Eva Muñoz-Couselo (14957498) Elena Garralda (15039090) Andreas Schlosser (15056560) Alena Gros (15056563) |
| dc.date.none.fl_str_mv | 2025-11-25T13:11:12Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30708063 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Data_S2_from_Exploring_the_Immunogenicity_of_Noncanonical_HLA-I_Tumor_Ligands_Identified_through_Proteogenomics/30708063 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Therapeutic Research and Development Immuno-oncology Immunology Immune responses to cancer Tumor antigens/neoantigens Immunotherapy Cancer vaccines Cellular immunotherapy Translational Research |
| dc.title.none.fl_str_mv | Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Includes the list of peptides derived from NSM identified at 0.02 FDR and ALC>=30</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_c2335cd410b481e2e56fbb2525afe4ee |
| identifier_str_mv | 10.1158/1078-0432.30708063 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30708063 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through ProteogenomicsMaria Lozano-Rabella (15056515)Andrea Garcia-Garijo (15056518)Jara Palomero (15056521)Anna Yuste-Estevanez (15056524)Florian Erhard (15056527)Roc Farriol-Duran (15056530)Juan Martín-Liberal (15056533)Maria Ochoa-de-Olza (15056536)Ignacio Matos (15056539)Jared J. Gartner (15046103)Michael Ghosh (15056542)Francesc Canals (15056545)August Vidal (15056548)Josep Maria Piulats (15056551)Xavier Matías-Guiu (15056554)Irene Brana (15056557)Eva Muñoz-Couselo (14957498)Elena Garralda (15039090)Andreas Schlosser (15056560)Alena Gros (15056563)CancerTherapeutic Research and DevelopmentImmuno-oncologyImmunologyImmune responses to cancerTumor antigens/neoantigensImmunotherapyCancer vaccinesCellular immunotherapyTranslational Research<p>Includes the list of peptides derived from NSM identified at 0.02 FDR and ALC>=30</p>2025-11-25T13:11:12ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30708063https://figshare.com/articles/dataset/Supplementary_Data_S2_from_Exploring_the_Immunogenicity_of_Noncanonical_HLA-I_Tumor_Ligands_Identified_through_Proteogenomics/30708063CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307080632025-11-25T13:11:12Z |
| spellingShingle | Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics Maria Lozano-Rabella (15056515) Cancer Therapeutic Research and Development Immuno-oncology Immunology Immune responses to cancer Tumor antigens/neoantigens Immunotherapy Cancer vaccines Cellular immunotherapy Translational Research |
| status_str | publishedVersion |
| title | Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics |
| title_full | Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics |
| title_fullStr | Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics |
| title_full_unstemmed | Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics |
| title_short | Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics |
| title_sort | Supplementary Data S2 from Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics |
| topic | Cancer Therapeutic Research and Development Immuno-oncology Immunology Immune responses to cancer Tumor antigens/neoantigens Immunotherapy Cancer vaccines Cellular immunotherapy Translational Research |